Abstract:Objective To examine the sex differences in prescribing patterns of psychotropic drugs and drug-induced side effects in schizophrenia patients in China. Methods Using the same design and a standardized protocol as in 2002 and 2006, the cross-sectional survey was conducted from July to August, 2012 in 45 psychiatric hospitals/centers in 10 provinces and municipalities in China. Inpatients and outpatients with schizophrenia were consecutively screened for eligibility for this study. Sociodemographic characteristics and prescription pattern were collected by using a modified questionnaire for the study. Data comparisons between male and female were performed with univariate analysis. Multiple logistic regression analysis was employed to determine the gender differences in prescription pattern and drug-induced side effects. Results The sample consisted of 2 260 male and 1 979 female patients. Univariate analyses showed that male patients were younger than female patients(t=5.398), having an earlier age at onset(t=5.662), higher percentage of being employed(χ2=31.597), and more negative symptoms(χ2=10.814)and aggressive behavior (χ2=5.816), more likely to receive clozapine (23.9%(472/1 979) vs. 28.5%(645/2 260),χ2=11.955), higher antipsychotic doses(476 mg vs. 514 mg,F=14.003), less use of antidepressants (7.9%(156/1 979) vs. 6.0%(136/2 260),χ2=5.722)and benzodiazepines(23.9%(472/1 979)vs. 20.0%(451/2 260),χ2=9.396), more frequent tardive dyskinesia(1.3%(25/1 979)vs. 2.1%(47/2 260),χ2=4.212)and less weight gain(11.0%(218/1 979)vs. 7.7%(173/2 260),χ2=14.233)and prolactin elevation(3.2%(63/1 979)vs. 1.7%(39/2 260),χ2=9.548;all P<0.05). In multivariate analyses, greater rate of clozapine use (OR=1.268,P=0.001), less rate of benzodiazepines use(OR=0.841,P=0.025) and antidepressants(OR=0.78,P=0.045),higher rate of tardive dyskinesia(OR=1.879,P=0.014)and less weight gain (OR=0.669,P=0.001) and prolactin elevation (OR=0.527,P=0.003) were independently associated with the male sex. Conclusion Gender is one of the independent contributors to psychotropic prescription pattern and side effects of antipsychotics in Chinese schizophrenia patients. Gender differences should be given more attention in research and clinical practice.

Sex Differences in Body Mass Index and Obesity in Chinese Patients with Chronic Schizophrenia

Sex Differences in Obesity and Cognitive Function in Chinese Elderly Patients with Chronic Schizophrenia.

Sex Difference in Effects of Typical and Atypical Antipsychotics on Glucose-Insulin Homeostasis and Lipid Metabolism in First-Episode Schizophrenia.

Sex Differences in Pharmacotherapy of Schizophrenia:Findings from National Survey 2012 on Use of Psychotropic Medications

Sex Differences in Patients with Schizophrenia: A Prospective, Multi-Center Study

Gender Differences of Schizophrenia Patients with and Without Depressive Symptoms in Clinical Characteristics.

Sex differences in plasma lipid profiles, but not in glucose metabolism in patients with first-episode antipsychotics-naïve schizophrenia

Male Sex May Be Associated with Higher Metabolic Risk in First-Episode Schizophrenia Patients: A Preliminary Study

The Relationship Between Obesity and Neurocognitive Function in Chinese Patients with Schizophrenia

Differing Prevalence and Correlates of Metabolic Syndromes Between Chlorpromazine and Clozapine: A 10-year Retrospective Study of a Male Chinese Cohort

The Relationship Between Obesity and Health-Related Quality of Life in Chinese Patients with Schizophrenia

Homocysteine level, body mass index and clinical correlates in Chinese Han patients with schizophrenia

Gender Differences in Prevalence and Associated Factors of Metabolic Syndrome in First-Treatment and Drug-Naïve Schizophrenia Patients.

Sex differences in prevalence and clinical correlates of insomnia in Chinese patients with chronic schizophrenia

Influencing Factors of Obesity in Community Patients with Deficit Schizophrenia: a Cross-Sectional Study

Metabolic Effects Of 7 Antipsychotics On Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial

Relationship Between Insulin Resistance, Dyslipidaemia and Positive Symptom in Chinese Antipsychotic-Naive First-Episode Patients with Schizophrenia

Gender Differences in Gut Microbiome Composition Between Schizophrenia Patients With Normal Body Weight and Central Obesity

Prevalence of metabolic syndrome and its related factors in schizophrenic inpatients

Prevalence, risk factors and clinical characteristics of osteoporosis in Chinese inpatients with schizophrenia

The prevalence, risk factors and clinical correlates of diabetes mellitus in Chinese patients with schizophrenia